搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
trvi
/
财务摘要
Trevi Therapeutics Inc
TRVI
添加自选
15.890
USD
-0.010
-0.06%
收盘 09-14 16:00(美东)
2.26B
总市值
亏损
市盈率 TTM
Trevi Therapeutics Inc
15.890
-0.010
-0.06%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
TRVI 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Trevi Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
2.26B
股息TTM
0.00
市盈率 TTM
-49.68
每股收益TTM
-0.32
营业收入
--
净利润
-47.91M
净资产收益率
-33.59%
总资产收益率
-31.83%
Trevi Therapeutics Inc 财报日历
最新发布
8月 6, 2026
每股收益 / 预测值
-0.11
/-0.11
营业收入 / 预测值
--
/0.00
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-20.42%
-0.11
-3.06%
-0.09
46.95%
-0.06
37.79%
-0.08
22.81%
-0.09
19.74%
-0.09
-36.94%
-0.11
-68.70%
-0.13
-68.88%
-0.12
-68.77%
-0.11
7.83%
-0.08
--
-0.08
--
-0.07
--
-0.06
--
-0.09
--
-0.44
--
--
--
--
--
--
--
--
净利润
-44.68%
-17.80M
-27.58%
-13.19M
27.15%
-8.32M
10.87%
-11.80M
0.41%
-12.30M
5.16%
-10.34M
-45.95%
-11.41M
-72.02%
-13.24M
-72.88%
-12.35M
-70.32%
-10.90M
-42.07%
-7.82M
6.87%
-7.70M
11.26%
-7.14M
12.66%
-6.40M
35.39%
-5.50M
-13.94%
-8.27M
17.79%
-8.05M
12.45%
-7.33M
10.53%
-8.52M
1.67%
-7.25M
资产负债率
--
--
--
--
-100.00%
0.00%
-100.00%
0.00%
-100.00%
0.00%
-100.00%
0.00%
-83.67%
0.03%
-52.85%
0.09%
-40.27%
0.13%
-97.63%
0.16%
-97.70%
0.17%
--
0.19%
--
0.21%
--
6.65%
--
7.44%
--
8.41%
--
--
--
--
--
--
--
--
利润表
营业利润
-49.46%
-20.51M
-30.01%
-14.91M
16.52%
-10.22M
1.21%
-13.92M
-3.26%
-13.72M
3.66%
-11.47M
-37.05%
-12.24M
-55.74%
-14.09M
-58.54%
-13.29M
-57.42%
-11.91M
-34.19%
-8.93M
-7.61%
-9.04M
-7.19%
-8.38M
-7.66%
-7.56M
19.53%
-6.66M
-20.99%
-8.40M
14.69%
-7.82M
13.15%
-7.03M
10.01%
-8.27M
4.10%
-6.95M
净利润
-44.68%
-17.80M
-27.58%
-13.19M
27.15%
-8.32M
10.87%
-11.80M
0.41%
-12.30M
5.16%
-10.34M
-45.95%
-11.41M
-72.02%
-13.24M
-72.88%
-12.35M
-70.32%
-10.90M
-42.07%
-7.82M
6.87%
-7.70M
11.26%
-7.14M
12.66%
-6.40M
35.39%
-5.50M
-13.94%
-8.27M
17.79%
-8.05M
12.45%
-7.33M
10.53%
-8.52M
1.67%
-7.25M
资产负债表
流动资产
57.17%
325.70M
66.75%
176.12M
75.14%
191.66M
194.49%
198.30M
187.30%
207.23M
37.59%
105.62M
24.99%
109.43M
-28.33%
67.34M
-27.30%
72.13M
-32.78%
76.77M
-28.60%
87.55M
-26.21%
93.95M
24.19%
99.21M
282.72%
114.20M
223.04%
122.62M
314.62%
127.32M
107.60%
79.89M
-29.22%
29.84M
-17.96%
37.96M
-44.38%
30.71M
流动负债总额
-5.46%
8.74M
3.63%
7.12M
-7.23%
9.75M
-0.90%
9.04M
36.86%
9.24M
30.14%
6.87M
80.44%
10.51M
76.36%
9.12M
43.32%
6.75M
-60.03%
5.28M
-56.54%
5.82M
-64.67%
5.17M
-69.47%
4.71M
2.60%
13.20M
5.31%
13.40M
47.69%
14.64M
64.01%
15.43M
141.05%
12.87M
129.05%
12.72M
62.43%
9.91M
总资产
58.64%
330.52M
67.85%
179.61M
74.43%
193.44M
189.31%
199.36M
182.26%
208.34M
36.21%
107.00M
24.05%
110.90M
-28.14%
68.91M
-26.90%
73.81M
-32.40%
78.56M
-27.32%
89.40M
-25.29%
95.90M
24.03%
100.98M
282.43%
116.20M
219.73%
123.02M
306.26%
128.36M
107.96%
81.41M
-29.11%
30.39M
-18.37%
38.48M
-43.46%
31.60M
总负债
-8.47%
9.01M
-0.90%
7.48M
-9.43%
10.20M
-3.73%
9.57M
28.94%
9.85M
21.24%
7.55M
64.18%
11.26M
58.11%
9.94M
29.34%
7.64M
-56.99%
6.22M
-55.93%
6.86M
-65.94%
6.29M
-71.75%
5.90M
-27.36%
14.47M
-27.31%
15.56M
-8.70%
18.46M
-2.40%
20.90M
3.88%
19.92M
7.81%
21.40M
-0.22%
20.22M
总权益
61.97%
321.51M
73.07%
172.13M
83.90%
183.24M
221.84%
189.79M
199.96%
198.49M
37.50%
99.46M
20.71%
99.64M
-34.19%
58.97M
-30.40%
66.17M
-28.90%
72.33M
-23.18%
82.55M
-18.46%
89.61M
57.11%
95.07M
872.30%
101.73M
529.34%
107.46M
865.76%
109.90M
241.20%
60.52M
-55.82%
10.46M
-37.41%
17.07M
-68.05%
11.38M
现金流量表
经营净额
-72.55%
-17.43M
-23.83%
-16.69M
20.09%
-7.63M
-13.86%
-10.88M
-16.33%
-10.10M
-28.76%
-13.48M
-50.18%
-9.55M
-31.28%
-9.56M
12.07%
-8.68M
-27.69%
-10.47M
-0.44%
-6.36M
15.12%
-7.28M
-59.89%
-9.88M
-15.58%
-8.20M
-1.64%
-6.33M
-18.44%
-8.58M
21.80%
-6.18M
6.41%
-7.09M
30.20%
-6.23M
-3.93%
-7.24M
投资净额
-4192.64%
-112.04M
270.49%
16.96M
-28.22%
-30.61M
-764.38%
-50.94M
-194.29%
-2.61M
-22.99%
-9.95M
-285.85%
-23.87M
-57.36%
7.67M
-85.91%
2.77M
-190.28%
-8.09M
126.59%
12.85M
470.76%
17.98M
136.22%
19.64M
--
8.96M
--
-48.31M
--
-4.85M
--
-54.22M
--
--
100.00%
0.00
100.00%
0.00
融资净额
48.88%
164.36M
-97.45%
222.00K
-99.45%
284.00K
-67.28%
1.63M
2078.71%
110.39M
31189.29%
8.71M
95409.26%
51.47M
229.67%
4.98M
166.12%
5.07M
98.36%
-28.00K
-108.28%
-54.00K
-97.27%
1.51M
-113.69%
-7.66M
-172.48%
-1.70M
-95.26%
652.00K
41170.15%
55.30M
1933.35%
55.98M
-115.07%
-625.00K
2057.14%
13.74M
-99.17%
134.00K
常见问题
Trevi Therapeutics Inc的流动资产是多少?
根据Trevi Therapeutics Inc的FY2025财报,流动资产为191.66M(同比变化75.14)。
Trevi Therapeutics Inc的总资产是多少?
根据Trevi Therapeutics Inc的FY2025财报,Trevi Therapeutics Inc的总资产为193.44M(同比变化74.43)。
Trevi Therapeutics Inc的总负债是多少?
根据Trevi Therapeutics Inc的FY2025财报,Trevi Therapeutics Inc的总负债为10.20M(同比变化-9.43)。
Trevi Therapeutics Inc的总权益是多少?
根据Trevi Therapeutics Inc的FY2025财报,Trevi Therapeutics Inc的总权益为183.24M(同比变化83.90)。
Trevi Therapeutics Inc的净营业收入是多少?
根据Trevi Therapeutics Inc的FY2025财报,Trevi Therapeutics Inc的净营业收入为-49.33M(同比变化4.26)。
Trevi Therapeutics Inc的净投资是多少?
根据Trevi Therapeutics Inc的FY2025财报,Trevi Therapeutics Inc的净投资为-94.11M(同比变化-337.14)。
Trevi Therapeutics Inc的净融资是多少?
根据Trevi Therapeutics Inc的FY2025财报,Trevi Therapeutics Inc的净融资为121.01M(同比变化96.82)。
Trevi Therapeutics Inc的每股收益(EPS)是多少?
根据Trevi Therapeutics Inc的FY2025财报,每股收益(EPS)为-0.32(同比变化32.46)。
Trevi Therapeutics Inc的净利润是多少?
根据Trevi Therapeutics Inc的FY2025财报,净利润为-42.76M(同比变化10.75)。
Trevi Therapeutics Inc的股东权益回报率(ROE)是多少?
根据Trevi Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-30.23(同比变化42.52)。
Trevi Therapeutics Inc的资产回报率(ROA)是多少?
根据Trevi Therapeutics Inc的FY2025财报,资产回报率(ROA)为-28.10(同比变化41.26)。
Trevi Therapeutics Inc的营业利润是多少?
根据Trevi Therapeutics Inc的FY2025财报,营业利润为-49.33M(同比变化4.26)。